{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-007972","form_type":"8-K","ticker":"HBIO","cik":"0001123494","company_name":"HARVARD BIOSCIENCE INC","filed_at":"2025-12-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.839535+00:00","generated_at":"2026-05-16T12:51:58.949701+00:00","sec_items":["1.01","1.02","2.03","5.02","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Harvard Bioscience closes $40M debt refinancing with BroadOak; extends maturity to 2029, appoints new director","bullets":["Enters $40M senior secured credit facility (Term A $10M, Term B $22.5M, Term C $7.5M convertible at $1.00) maturing Dec 17, 2029","Issues warrants to purchase 2M shares of common stock at $0.50 per share; proceeds repay existing Citizens Bank credit facility","Quarterly amortization on Term A/B begins Dec 31, 2027; amortization and maturity can extend 1 year upon EBITDA milestone","Appoints Bill Snider (BroadOak Partner) to Board and Compensation Committee; will form Product, Operations & Scientific Advisory Board"],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-007972","json":"https://secwatch.observer/filing/0001171843-25-007972.json","markdown":"https://secwatch.observer/filing/0001171843-25-007972.md","text":"https://secwatch.observer/filing/0001171843-25-007972.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1123494/000117184325007972/0001171843-25-007972-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1123494/000117184325007972/f8k_121625.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:51:58.949701+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19b630affc973a6eb46c2dd5c31730e68b5bf506","claim":"HARVARD BIOSCIENCE INC incurred term loan of $10.0 million with BroadOak Income Fund, L.P. at greater of (i) 12.80% from the date of the Loan Agreement through the Loan Agree maturing December 17, 2029.","evidence_excerpt":"The Loan Agreement provides for the following term loans: (i) a term loan in an aggregate principal amount of $10.0 million (the “Term A Loan”), (ii) a term loan in an aggregate principal amount of $22.5 million (the “Term B Loan”) and (iii) a term loan in an aggregate principal amount of $7.5 million (the “Term C Loan”","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1123494/000117184325007972/0001171843-25-007972-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"$10.0 million"},{"label":"Counterparty","value":"BroadOak Income Fund, L.P."},{"label":"Rate","value":"greater of (i) 12.80% from the date of the Loan Agreement through the Loan Agree"},{"label":"Maturity","value":"December 17, 2029"},{"label":"Event","value":"incurrence"}]},{"claim_id":"3241dbf3f7306966732db3773aa7b732e453b94d","claim":"HARVARD BIOSCIENCE INC incurred convertible notes of $7.5 million with BroadOak Income Fund, L.P. at greater of (i) 12.80% from the date of the Loan Agreement through the Loan Agree maturing December 17, 2029.","evidence_excerpt":"The Loan Agreement provides for the following term loans: (i) a term loan in an aggregate principal amount of $10.0 million (the “Term A Loan”), (ii) a term loan in an aggregate principal amount of $22.5 million (the “Term B Loan”) and (iii) a term loan in an aggregate principal amount of $7.5 million (the “Term C Loan”","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1123494/000117184325007972/0001171843-25-007972-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$7.5 million"},{"label":"Counterparty","value":"BroadOak Income Fund, L.P."},{"label":"Rate","value":"greater of (i) 12.80% from the date of the Loan Agreement through the Loan Agree"},{"label":"Maturity","value":"December 17, 2029"},{"label":"Event","value":"incurrence"}]},{"claim_id":"72e8aef98b505f4024348fdcec6946f35cbb8998","claim":"HARVARD BIOSCIENCE INC incurred term loan of $22.5 million with BroadOak Income Fund, L.P. at greater of (i) 12.80% from the date of the Loan Agreement through the Loan Agree maturing December 17, 2029.","evidence_excerpt":"The Loan Agreement provides for the following term loans: (i) a term loan in an aggregate principal amount of $10.0 million (the “Term A Loan”), (ii) a term loan in an aggregate principal amount of $22.5 million (the “Term B Loan”) and (iii) a term loan in an aggregate principal amount of $7.5 million (the “Term C Loan”","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1123494/000117184325007972/0001171843-25-007972-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"$22.5 million"},{"label":"Counterparty","value":"BroadOak Income Fund, L.P."},{"label":"Rate","value":"greater of (i) 12.80% from the date of the Loan Agreement through the Loan Agree"},{"label":"Maturity","value":"December 17, 2029"},{"label":"Event","value":"incurrence"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}